Latest news

Top 10 Barriers to Scaling Genomics Programs in Healthcare

Executive Summary Genomics is rapidly becoming a cornerstone of modern healthcare. Advances in next-generation sequencing (NGS), precision medicine, artificial intelligence...

Xiaflex Meets Phase 3 Endpoints in Plantar Fibromatosis Study

Keenova Therapeutics reported positive phase 3 results for Xiaflex in patients with plantar fibromatosis, potentially positioning the injectable biologic...

Leo Cancer Care Raises $65 Million Series D Round to Expand Upright Radiotherapy Platform

Medical technology company Leo Cancer Care has closed a $65 million Series D financing round to support the expansion...

The Rise of AI-Native Biotech Companies

Executive Summary Artificial intelligence is reshaping nearly every aspect of the life sciences industry. Most pharmaceutical and biotechnology companies are integrating...

Novartis Set to Buy UK Biotech Myricx For Over $1.1B

Novartis is expanding its presence in the antibody-drug conjugate...

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

The Roche subsidiary has just announced that the restructuring...

FDA Expands Casgevy Approval to Children Aged 2 With Sickle Cell Disease and Beta Thalassemia

The U.S. Food and Drug Administration (FDA) has expanded the approved use of Casgevy, allowing children as young as...

In its biggest-ever transaction, Vertex pays $10 billion to buy endocrine disease expert Crinetics

Vertex Pharmaceuticals is making its biggest-ever acquisition to date, to the tune of $10 billion, of Crinetics Pharmaceuticals. While...

Phase 3 KRYSTAL-10 Study Fails to Meet Primary Endpoints for Krazati in Metastatic Colorectal Cancer

Bristol Myers Squibb has disclosed detailed results from the phase 3 KRYSTAL-10 trial evaluating Krazati (adagrasib) in combination with...

Kailera and Hengrui Report Phase 3 Results for Oral GLP-1 Drug in Obesity and Type 2 Diabetes

Kailera Therapeutics and its partner Jiangsu Hengrui Pharmaceutical reported...

Phase 3 NSCLC study for Pfizer’s first novel ADC from the acquisition of Seagen fails

The big gamble that Pfizer made on antibody-drug conjugates...

Top 10 Reasons Precision Medicine Requires Better Data Integration

Executive Summary Precision medicine is transforming healthcare by shifting treatment decisions from population-based approaches to strategies tailored to individual patients....

Why Pharma Supply Chains Need a Resilience-First Strategy

Executive Summary For decades, pharmaceutical supply chains were primarily designed for efficiency. Organizations optimized manufacturing networks, supplier relationships, inventory levels, and...

Orca Bio Gets FDA Green Light For Tregzi; IPO a Real Possibility

Orca Bio has officially entered the commercial marketplace after securing the FDA nod for Tregzi, the first engineered cell...

Highridge Medical: ZimVie’s successful spinout of its spine division

The successful sale of ZimVie's spine division to investment...

Popular

Most popular life news you must read today

Commercial

Information Technology

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...

Regulatory

Xiaflex Meets Phase 3 Endpoints in Plantar Fibromatosis Study

Keenova Therapeutics reported positive phase 3 results for Xiaflex...

The Rise of AI-Native Biotech Companies

Executive Summary Artificial intelligence is reshaping nearly every aspect of...

Why Every Pharma Company Is Becoming a Technology Company

Executive Summary For much of its history, the pharmaceutical industry...

Research & Development

Market Access

Vivtex Expands R&D and Workforce Following $2.1 Billion Novo Nordisk Partnership

Despite securing a partnership valued at up to $2.1...

UCB to Build $2 Billion Biologics Manufacturing Facility in Georgia

Belgium-based UCB has announced plans to invest $2 billion...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Top 10 Barriers to Scaling Genomics Programs in Healthcare

Executive Summary Genomics is rapidly becoming a cornerstone of modern...